Nextblockbuster, imo they would have a better chance of getting EUA for Congestive Heart Failure because we have impressive and substantial statistically significant human clinical proof from a Phase III CVD trial.  We have virtually zero in-patient data for COVID except the few from a stopped Phase II. 

I do think though that they should be lobbying right now for an understanding from the FDA that we get EUA on positive data from the upcoming COVID Phase III data.  Heck, they may as well start by asking for EUA at an interim analysis.

Don's mantra should be:  PUSH PUSH PUSH! COM'ON, LET'S GO !!